Marc Iskowitz speaks with Novartis’ Janie Vitlina and Ipsos’ Steve Reeves about a new approach to understanding how information flows within treatment categories, and Lecia Bushak offers an update on HHS Secretary Becerra’s comment that the government is considering further drug pricing regulation, including possibly “march-in” rights.
MM+M Podcast 10.13.22: Novartis maps a digital ecosystem, U.S. mulls ‘march-in’ rights
Marc Iskowitz speaks with Novartis' Janie Vitlina and Ipsos' Steve Reeves about a new approach to understanding how information flows within treatment categories, and Lecia Bushak offers an update on HHS Secretary Becerra's comment that the government is considering further drug pricing regulation, including possibly "march-in" rights.
